LIFR belongs to the gp130 receptor family, which has been recognized as a tumor suppressor gene in multiple types of cancers [40], including breast [21–23], hepatocellular [24–26], and pancreatic cancers [41]. Here, LIFR is linked to familial pancreatic carcinoma.